BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOS was delisted on the 6th of October, 2023.

Back to rankings

56 hedge funds and large institutions have $173M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$99K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.2M
2
+$11.7M
3
+$9.88M
4
Millennium Management
Millennium Management
New York
+$9.78M
5
Goldman Sachs
Goldman Sachs
New York
+$8.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.47M
27
$2.47M
28
$2.46M
29
$2.4M
30
$2.08M
31
$1.48M
32
$1.48M
33
$1.48M
34
$1.24M
35
$1.24M
36
$1.16M
37
$1.01M
38
$988K
39
$988K
40
$871K
41
$658K
42
$630K
43
$494K
44
$494K
45
$493K
46
$356K
47
$356K
48
$247K
49
$247K
50
$247K
1
2
3